全文获取类型
收费全文 | 4552篇 |
免费 | 299篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 135篇 |
妇产科学 | 108篇 |
基础医学 | 715篇 |
口腔科学 | 67篇 |
临床医学 | 458篇 |
内科学 | 889篇 |
皮肤病学 | 222篇 |
神经病学 | 556篇 |
特种医学 | 155篇 |
外科学 | 364篇 |
综合类 | 19篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 449篇 |
眼科学 | 72篇 |
药学 | 252篇 |
中国医学 | 17篇 |
肿瘤学 | 368篇 |
出版年
2024年 | 7篇 |
2023年 | 35篇 |
2022年 | 42篇 |
2021年 | 153篇 |
2020年 | 101篇 |
2019年 | 141篇 |
2018年 | 153篇 |
2017年 | 104篇 |
2016年 | 142篇 |
2015年 | 139篇 |
2014年 | 216篇 |
2013年 | 256篇 |
2012年 | 380篇 |
2011年 | 382篇 |
2010年 | 228篇 |
2009年 | 205篇 |
2008年 | 291篇 |
2007年 | 288篇 |
2006年 | 311篇 |
2005年 | 294篇 |
2004年 | 256篇 |
2003年 | 215篇 |
2002年 | 176篇 |
2001年 | 28篇 |
2000年 | 23篇 |
1999年 | 26篇 |
1998年 | 32篇 |
1997年 | 23篇 |
1996年 | 29篇 |
1995年 | 22篇 |
1994年 | 17篇 |
1993年 | 11篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 5篇 |
1988年 | 8篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 11篇 |
1984年 | 8篇 |
1983年 | 4篇 |
1981年 | 8篇 |
1980年 | 4篇 |
1975年 | 5篇 |
1974年 | 4篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1971年 | 4篇 |
1968年 | 4篇 |
1963年 | 5篇 |
排序方式: 共有4870条查询结果,搜索用时 319 毫秒
61.
62.
63.
Niek Hugen MD Jasper J. P. van Beek BSc Johannes H. W. de Wilt MD Iris D. Nagtegaal MD 《Annals of surgical oncology》2014,21(9):2963-2970
The prognostic impact of mucinous carcinoma (MC) in colorectal cancer (CRC) has been subject to debate ever since the introduction of the classification of tumors according to their histological differentiation. MC is a distinct clinical and pathological entity within the spectrum of CRC and accounts for approximately 10–15 % of cases. Factors involved in MC development have not been completely understood, but clinical observations may lead to a better insight into the etiology of MC. In this article, we provide an in-depth review of the literature regarding etiological aspects of MC. We show that there are worldwide differences in the prevalence of MC, with low rates in Asian countries and higher rates in the western world. Moreover, MC is more commonly diagnosed in patients suffering from inflammatory bowel diseases or Lynch syndrome and an increased rate of MC is observed in patients with radiotherapy-induced CRCs. These findings are suggestive of a different oncogenic development. Identification of conditions that are associated with MC generates insight into the etiological pathways leading to the development of this special subtype. 相似文献
64.
65.
66.
67.
68.
69.
Ellen Strijbos Martijn R. Tannemaat Iris Alleman Robert H.P. de Meel Jaap A. Bakker Ruud van Beek Frank P. Kroon Guus F. Rimmelzwaan Jan J.G.M. Verschuuren 《Vaccine》2019,37(7):919-925
Objective
To investigate the efficacy and safety of an influenza vaccination in patients with myasthenia gravis with acetylcholine receptor antibodies (AChR MG).Methods
An influenza vaccination or placebo was administered to 47 AChR MG patients. Before and 4?weeks after administration blood samples and clinical outcome scores were obtained. Antibodies to the vaccine strains A/California/7/2009 (H1N1)pdm09, A/Hong Kong/4801/14 (H3N2) and B/Brisbane/060/08 were measured using the hemagglutination-inhibition (HI) assay and disease-specific AChR antibody titers were measured with a radio-immunoprecipitation assay. Forty-seven healthy controls (HC) were vaccinated with the same influenza vaccine to compare antibody titers.Results
A post-vaccination, seroprotective titer (HI?≥?1:40) was achieved in 89.4% of MG patients vs. 93.6% in healthy controls for the H3N2 strain, 95.7% vs 97.9% for the H1N1 strain and 46.8 vs 51% for the B-strain. A seroprotective titer for all three strains of the seasonal influenza vaccine was reached in 40.4% (19/47) of the MG group and in 51% (24/47) of the HC group. Immunosuppressive medication did not significantly influence post geomean titers (GMT). The titers of disease-specific AChR antibodies were unchanged 4?weeks after vaccination. The clinical outcome scores showed no exacerbation of MG symptoms.Conclusion
The antibody response to an influenza vaccination in patients with AChR MG was not different from that in healthy subjects, even in AChR MG patients using immunosuppressive medication. Influenza vaccination does not induce an immunological or clinical exacerbation of AChR MG.Clinical trial registry
The influenza trial is listed on clinicaltrialsregister.eu under 2016-003138-26. 相似文献70.